SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-03-011223
Filing Date
2003-03-31
Accepted
2003-03-31 15:15:32
Documents
4
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2106594z10-k.htm 10-K 494755
3 EXHIBIT 10.37 a2106594zex-10_37.htm EX-10.37 54760
4 EXHIBIT 23.2 a2106594zex-23_2.htm EX-23.2 2243
5 EXHIBIT 99.0 a2106594zex-99_0.htm EX-99.0 5002
  Complete submission text file 0001047469-03-011223.txt   558672
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 03629974
SIC: 2836 Biological Products, (No Diagnostic Substances)